Molecular Partners AG (MOLN) Earnings Date & Reports
Molecular Partners AG is a clinical stage biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
MOLN is expected to report earnings to fall 34.07% to -44 cents per share on August 25
Q2'26
Est.
$-0.44
Q1'26
Missed
by $0.28
Q4'25
Missed
by $0.04
Q3'25
Beat
by $0.08
Q2'25
Missed
by $0.18
The last earnings report on May 12 showed earnings per share of -67 cents, missing the estimate of -38 cents. With 611.00 shares outstanding, the current market capitalization sits at 147.40M.